Search

everythinglearnresearchcommunity

for

Search:↓

The Princeton III Consensus recommends assessing cardiovascular risk in men with erectile dysfunction and prioritizing heart health before treating ED, especially in those with potential heart disease.

Transverse sections are better for non-scarring hair loss, vertical sections are better for lichen planopilaris, and either method works for other scarring hair loss types.

Hair transplant works well, but needs more research for better results.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

AGA linked to worse COVID-19 outcomes in men.

Women with high androgen levels may have more severe COVID-19 symptoms.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Indigenous herbal medicines in the Indian subcontinent have potential for drug development but need more research and standardization.

Ashy dermatosis may be linked to atopy and thyroid disease and can be treated with topical steroids.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

X-ray microbeams can mimic cosmic rays' effects on tissue, aiding wound healing and hair growth.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

A combined Dermatology and Rheumatology Clinic showed that skin issues often weren't linked to rheumatic diseases, highlighting the benefits of a team approach.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

The authors updated the criteria for diagnosing frontal fibrosing alopecia, making it easier to diagnose without a biopsy.

Men are more likely to have larger basal cell carcinomas and squamous cell carcinomas, while women have more superficial basal cell carcinomas and tumors on their legs and central face.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

Zidovudine may cause hair loss in advanced-stage HIV patients.

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

Melanoma thickness at diagnosis is linked to access to dermatologists and preventive services, not to socioeconomic status.

Eyebrow tinting can cause chemical burns and increased awareness of its risks is needed.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.